A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Lee, C E ^a   Leslie, William D ^a   Lau, Y K J ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Androgen deprivation therapy; Bone health; Home based exercise; Physical function; Prostate cancer; Quality of life; Walking

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; COGNITION; CONTROLLED STUDY; EXERCISE; FITNESS; FUNCTIONAL ASSESSMENT; HOME CARE; HUMAN; MALE; MUSCULOSKELETAL FUNCTION; PHYSICAL ACTIVITY; PILOT STUDY; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SHORT FORM 12; SINGLE BLIND PROCEDURE; WALKING; ANALYSIS OF VARIANCE; BODY COMPOSITION; BODY MASS; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; KINESIOTHERAPY; MUSCULOSKELETAL DISEASE; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PROSPECTIVE STUDY; PROSTATE TUMOR;

ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ABSORPTIOMETRY, PHOTON; ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; EXERCISE THERAPY; HUMANS; MALE; MUSCULOSKELETAL DISEASES; PILOT PROJECTS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SINGLE-BLIND METHOD; WALKING;

EID: 84862791247     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-103     Document Type: Article

References (34)

1. Canadian Cancer Society Prostate Cancer Statistics. 2010, 2010, Canadian Cancer Society.
2. Stat Fact Sheets: Prostate Cancer. , http://seer.cancer.gov/statfacts/html/prost.html
3. Abraham J, Allegra C, Gulley J. Bethesda Handbook of Clinical Oncology. 2005, Baltimore, MD: Lippincott Williams & Wilkins, 2.
4. Saad F, Perrotte P, Benard F, McCormack M, Karakiewicz PI. Bone health in men with prostate cancer: diagnostic and therapeutic considerations. Can J Urol 2005, 12(Suppl 2):9-15.
5. Yaturu S, DjeDjos S, Alferos G, Deprisco C. Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy. Prostate Cancer Prostatic Dis 2006, 9(1):35-38. 10.1038/sj.pcan.4500846, 16276350.
6. Melton LJ, Lieber MM, Atkinson EJ, Achenbach SJ, Zincke H, Therneau TM, Khosla S. Fracture risk in men with prostate cancer: a population-based study. J Bone Miner Res 2011, 26(8):1808-1815. 10.1002/jbmr.405, 21520274.
7. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005, 352(2):154-164. 10.1056/NEJMoa041943, 15647578.
8. Lau YK, Lee CE, Prior HJ, Lix LM, Metge CJ, Leslie WD. Fracture risk in androgen deprivation therapy: a Canadian population based analysis. Can J Urol 2009, 16(6):4908-4914.
9. Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Greenspan SL. Physical function in men with prostate cancer on androgen deprivation therapy. PhysTher 2007, 87(10):1325-1333.
10. Dacal K, Sereika SM, Greenspan SL. Quality of life in prostate cancer patients taking androgen deprivation therapy. J Am GeriatrSoc 2006, 54(1):85-90.
11. Chen AC, Petrylak DP. Complications of androgen-deprivation therapy in men with prostate cancer. CurrUrol Rep 2005, 6(3):210-216.
12. Holzbeierlein JM, McLaughlin MD, Thrasher JB. Complications of androgen deprivation therapy for prostate cancer. CurrOpinUrol 2004, 14(3):177-183.
13. Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 2004, 29(8):1071-1081. 10.1016/j.psyneuen.2003.11.002, 15219659.
14. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. Arch Intern Med 2006, 166(4):465-471. 10.1001/.465, 2222554, 16505268.
15. Cawthon PM, Fullman RL, Marshall L, Mackey DC, Fink HA, Cauley JA, Cummings SR, Orwoll ES, Ensrud KE. Physical performance and risk of hip fractures in older men. J Bone Miner Res 2008, 23(7):1037-1044. 10.1359/jbmr.080227, 2679379, 18302496.
16. Malcolm JB, Derweesh IH, Kincade MC, DiBlasio CJ, Lamar KD, Wake RW, Patterson AL. Osteoporosis and fractures after androgen deprivation initiation for prostate cancer. Can J Urol 2007, 14(3):3551-3559.
17. Nevitt MC, Cummings SR, Kidd S, Black D. Risk factors for recurrent nonsyncopal falls. A prospective study. JAMA 1989, 261(18):2663-2668. 10.1001/jama.1989.03420180087036, 2709546.
18. Stel VS, Smit JH, Pluijm SM, Lips P. Balance and mobility performance as treatable risk factors for recurrent falling in older persons. J ClinEpidemiol 2003, 56(7):659-668.
19. McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006, 175(1):34-41. 10.1503/cmaj.051073, 1482759, 16818906.
20. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005, 293(20):2479-2486. 10.1001/jama.293.20.2479, 15914748.
21. Yamazaki S, Ichimura S, Iwamoto J, Takeda T, Toyama Y. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis. J Bone Miner Metab 2004, 22(5):500-508.
22. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J ClinOncol 2003, 21(9):1653-1659.
23. Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci 1992, 17(4):338-345.
24. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982, 14(5):377-381.
25. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 1997, 50(6):920-928. 10.1016/S0090-4295(97)00459-7, 9426724.
26. Chang CH, Wright BD, Cella D, Hays RD. The SF-36 physical and mental health factors were confirmed in cancer and HIV/AIDS patients. J ClinEpidemiol 2007, 60(1):68-72.
27. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997, 13(2):63-74. 10.1016/S0885-3924(96)00274-6, 9095563.
28. Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol A BiolSci Med Sci 1995, 50A(1):M28-M34.
29. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A BiolSci Med Sci 2000, 55(4):M221-M231.
30. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994, 49(2):M85-M94.
31. Enright PL. The six-minute walk test. Respir Care 2003, 48(8):783-785.
32. Wallston KA, Stein MJ, Smith CA. Form C of the MHLC scales: a condition-specific measure of locus of control. J Pers Assess 1994, 63(3):534-553. 10.1207/s15327752jpa6303_10, 7844739.
33. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 1999, 46(5):437-443. 10.1016/S0022-3999(99)00004-5, 10404478.
34. Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The Rapid Assessment of Physical Activity (RAPA) among older adults. Prev Chronic Dis 2006, 3(4):A118. 1779282, 16978493.